Related Experiment Video
Updated: May 8, 2025

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
[Treatment Strategies for Chronic Inflammatory Demyelinating Polyneuropathy]
1Department of Neurology, Dokkyo Medical University.
Abstract:
Three main treatments are available for management of chronic inflammatory demyelinating polyneuropathy (CIDP). Both induction and maintenance therapies should be considered for treatment of CIDP. Plasma exchange and intravenous immunoglobulin therapy are effective as induction treatments for CIDP, and corticosteroid administration, such as daily oral or pulse therapies, may be effective for both induction and maintenance. Recently, repeat intravenous or subcutaneous immunoglobulin infusion therapy has been introduced as maintenance treatment. Treatment strategies, including combinations of the aforementioned approaches, are required as induction and maintenance therapies for patients with CIDP.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Treatment
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Chronic Pancreatitis II: Collaborative Care
Assessment:

